Literature DB >> 5060065

Musculoperiosteal flap in cavity obliteration. Histopathological study seven years postoperatively.

T Palva, A Palva, J Kärjä.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 5060065     DOI: 10.1001/archotol.1972.00770080260016

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


× No keyword cloud information.
  5 in total

Review 1.  [Obliteration of mastoid cavities: 30 years of experience with recommendations for surgical strategy].

Authors:  G Schimanski; E Schimanski
Journal:  HNO       Date:  2015-08       Impact factor: 1.284

2.  Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results.

Authors:  Bartłomiej Król; Katarzyna Beata Cywka; Magdalena Beata Skarżyńska; Piotr Henryk Skarżyński
Journal:  Life (Basel)       Date:  2021-04-22

3.  Mastoid Obliteration with S53P4 Bioactive Glass Can Make Bonebridge Implantation Feasible: A Case Report.

Authors:  Bartłomiej Król; Marek Porowski; Katarzyna B Cywka; Magdalena B Skarżyńska; Piotr Henryk Skarżyński
Journal:  Am J Case Rep       Date:  2020-11-10

4.  Obliteration of radical cavities with autogenous cortical bone; long-term results.

Authors:  Akram M Abdel-Rahman; Matti Pietola; Teemu J Kinnari; Hans Ramsay; Jussi Jero; Antti A Aarnisalo
Journal:  BMC Ear Nose Throat Disord       Date:  2008-07-29

5.  Clinical Significance of β-Tricalcium Phosphate and Polyphosphate for Mastoid Cavity Obliteration during Middle Ear Surgery: Human and Animal Study.

Authors:  Han-Bin Lee; Hye Jin Lim; Minhyuk Cho; Suk-Min Yang; Keehyun Park; Hun Yi Park; Yun-Hoon Choung
Journal:  Clin Exp Otorhinolaryngol       Date:  2013-09-04       Impact factor: 3.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.